^
Association details:
Biomarker:No biomarker
Cancer:Waldenstrom Macroglobulinemia
Drug:Calquence (acalabrutinib) (BTK inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Waldenstrom’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: Other recommended regimens…Acalabrutinib